AnaptysBio, Inc. ANAB Biopharma Company — General And Administrative Expense

Other segment segments

Similar metrics at other companies

VRTXPharmaceuticals — General and administrative expenses

$180.1M+16.0%

BEAMExternal General And Administrative Expenses — General And Administrative Expense

$13.37M+149%

MANEG&A

$8.94M+509%

PLYXG&A

$1.28M+281%

PFEBiopharma — Selling, informational and administrative expenses

$2.13B-2.5%

SNDXBiopharmaceutical Cancer Therapeutics — Other General And Administrative Expense

$5.14M+16.5%

Questions, answered.

What is AnaptysBio, Inc.'s biopharma company — general and administrative expense?

AnaptysBio, Inc. (ANAB) reported biopharma company — general and administrative expense of $18.86M in Q1 2026.

How has AnaptysBio, Inc.'s biopharma company — general and administrative expense changed year-over-year?

AnaptysBio, Inc.'s biopharma company — general and administrative expense increased by 92.1% year-over-year, from $9.82M to $18.86M.

What does biopharma company — general and administrative expense mean?

This metric captures the overhead costs required to support the company's operations, including executive compensation, legal, finance, and other corporate functions. It reflects the administrative burden of maintaining the business infrastructure outside of direct R&D activities. Investors monitor this to evaluate the company's operational discipline and cost management efficiency.